First-in-class First-in-human Phase 1 Trial and Translational Study of the Mono(adp-Ribose) Polymerase-7 (PARP7) Inhibitor RBN-2397 in Patients with Selected Advanced Solid Tumors
CANCER RESEARCH(2023)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined